Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
33.3%
% of PJP's 30 holdings also in MEDX
33.3%
% of MEDX's 30 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 5.3% | 5.3% | 5.3% |
|
ELI LILLY & CO | 5.3% | 18.6% | 5.3% |
|
AMGEN INC | 5.0% | 6.2% | 5.0% |
|
ABBVIE INC | 4.8% | 8.8% | 4.8% |
|
PFIZER INC | 4.7% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to MEDX
|
ABBOTT LABORATORIES | 5.4% |
|
GILEAD SCIENCES INC | 5.3% |
|
BIOSANTE PHARMACEUTICALS INC | 3.9% |
|
TARSUS PHARMACEUTICALS, INC. | 3.7% |
|
CORCEPT THERAPEUTICS INC | 3.1% |
|
INNOVIVA, INC. | 3.1% |
 |
PERRIGO CO | 3.1% |
|
PACIRA PHARMACEUTICALS INC | 3.0% |
|
SUPERNUS PHARMACEUTICALS INC | 2.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 2.9% |
PJP Underweight Relative to MEDX
|
ELI LILLY & CO | -13.4% |
 |
NOVARTIS AG-ADR | -7.0% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.5% |
|
ALKERMES PLC | -4.1% |
|
ABBVIE INC | -4.0% |
|
BRISTOL-MYERS SQUIBB CO | -3.2% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.6% |
|
IONIS PHARMACEUTICALS, INC. | -2.3% |